New hope for tough cancers: early trial tests novel therapy
Disease control
Recruiting now
This study is testing a new drug called MB0151 in adults with advanced solid tumors that have progressed after standard treatments. The main goals are to find a safe dose and see if the drug can shrink or control tumors. The trial is open to people with specific cancers, includin…
Phase: PHASE1, PHASE2 • Sponsor: Mainline Biosciences (Shanghai) Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC